Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Key drug regulatory changes take effect in Russia

This article was originally published in SRA

Executive Summary

Pharma firms in Russia are facing major regulatory changes and new legal responsibilities despite a last-minute attempt by the authorities to postpone the provisions until next year so as to allow more time to prepare for their introduction. Among the measures are shorter approval times for new medicines, and new rules on biologics, pharmacovigilance and product interchangeability.

Advertisement
Advertisement
UsernamePublicRestriction

Register